FDA‐Approved Pyrimidine‐Containing Drugs: Synthesis and Clinical Application
Medicinal Research Reviews · 2026-05 · 46 (3) · 713-748
DOI: 10.1002/med.70027 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Medicinal Research Reviews, online erschienen am 20.11.2025. Verfasst von Yao Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China. Hauptthemen laut MEDLINE: Pyrimidines, Drug Approval. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 157 Literaturangaben.
Abstract (Originalsprache)
Since 2013, a rapidly expanding portfolio of U.S. Food and Drug Administration (FDA)‐approved drugs has highlighted pyrimidine as one of the most versatile and therapeutically valuable heteroaromatic scaffolds. Building on more than six decades of medicinal chemistry, these recent approvals underscore the pivotal role of pyrimidines in modern drug discovery across oncology, anti‐infectives, immunology, immuno‐oncology, neurological disorders, chronic pain, and metabolic diseases. This review systematically surveys pyrimidine‐containing drugs approved from 2013 to the present, detailing their synthetic strategies, key biological targets, and disease‐specific mechanisms of action. This review demonstrates the enduring value of pyrimidine as a privileged chemotype and bioisostere for phenyl and other aromatic π‐systems, offering insights to guide the design of next‐generation therapeutics for conditions once considered intractable.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.
- Department of Infectious Diseases, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.
- Department of Anorectal Surgery, The First Hospital of China Medical University, Shenyang, Liaoning, China.
- Department of Thyroid Surgery, The First Hospital of China Medical University, Shenyang, Liaoning, China.
ORCID-Profile: Xiaomei Liu, Yanke Li, Zhenhua Du
Zitieren
APA
Zhang, Y., Liu, X., Zhang, C., Li, Y., Zhang, G., & Du, Z. (2026). FDA‐Approved Pyrimidine‐Containing Drugs: Synthesis and Clinical Application. Medicinal Research Reviews, 46(3), 713-748. https://doi.org/10.1002/med.70027
Vancouver
Zhang Y, Liu X, Zhang C, Li Y, Zhang G, Du Z. FDA‐Approved Pyrimidine‐Containing Drugs: Synthesis and Clinical Application. Medicinal Research Reviews. 2026;46(3):713-748. doi:10.1002/med.70027
BibTeX
@article{Zhang2026,
author = {Zhang, Yao and Liu, Xiaomei and Zhang, Chong and Li, Yanke and Zhang, Guangzhe and Du, Zhenhua},
title = {FDA‐Approved Pyrimidine‐Containing Drugs: Synthesis and Clinical Application},
journal = {Medicinal Research Reviews},
year = {2026},
volume = {46},
number = {3},
pages = {713--748},
doi = {10.1002/med.70027}
}
EUVIMED